PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO) announced a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing process commonly used with injectable and biologic therapies, with the investment of 100 Million USD into the construction and enhancement of world-class facilities, at its Bedford, New Hampshire campus.
- Read more about PCI Pharma Services Announces Major Manufacturing Expansion with 100 Million USD Investment in New England
- Log in or register to post comments
source https://www.pharmatutor.org/content/may-2022/pci-pharma-services-announces-major-manufacturing-expansion-with-100-million-usd-investment-in-new-england
No comments:
Post a Comment